{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-011242","form_type":"8-K","ticker":"SER","cik":"0001708599","company_name":"Serina Therapeutics, Inc.","filed_at":"2023-04-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.148277+00:00","generated_at":"2026-06-17T05:14:15.180348+00:00","sec_items":["2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"AgeX draws remaining $1M under secured note; issues warrants for 756K shares","bullets":["Drew $1M from Juvenescence under Amended and Restated Secured Convertible Promissory Note dated Feb 9, 2023.","Repayment date for outstanding principal is February 14, 2024.","Issued warrants to purchase 756,429 shares of common stock at $0.661 per share.","Warrants issued in connection with the drawdown; exercise price based on March 30, 2023 closing price."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-011242","json":"https://secwatch.observer/filing/0001493152-23-011242.json","markdown":"https://secwatch.observer/filing/0001493152-23-011242.md","text":"https://secwatch.observer/filing/0001493152-23-011242.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708599/000149315223011242/0001493152-23-011242-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708599/000149315223011242/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T05:14:15.180348+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fce726b642e8902b82c4d24effcd454aa1bbba15","claim":"Serina Therapeutics, Inc. incurred convertible notes of $1 million with Juvenescence Limited maturing February 14, 2024.","evidence_excerpt":"On April 4, 2023, AgeX drew the remaining $1 million of its credit available under the Amended and Restated Secured Convertible Promissory Note (“Secured Note”) dated February 9, 2023 with Juvenescence Limited (“Juvenescence”).","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1708599/000149315223011242/0001493152-23-011242-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$1 million"},{"label":"Counterparty","value":"Juvenescence Limited"},{"label":"Maturity","value":"February 14, 2024"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}